Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

personalized liposomal neoantigen-based peptide vaccine EVX-01

A personalized liposomal peptide vaccine composed of specific cancer neoepitopes, which are highly patient-specific immunogenic tumor associated antigens (TAAs), with potential immunostimulatory and antineoplastic activities. Upon administration of the personalized liposomal neoantigen-based peptide vaccine EVX-01, the neoepitopes induce cytotoxic T-lymphocyte (CTL)-mediated immune responses against tumor cells expressing these specific TAAs.
Synonym:liposomal peptide vaccine EVX-01
liposomal peptide-based vaccine EVX-01
Code name:EVX 01
EVX-01
EVX01
Search NCI's Drug Dictionary